Carol Bretschneider, MD
Urogynecology and Reconstructive Pelvic Surgery · Chicago, ILNPI 1700146826
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (38.6%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 62.6% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $4,767 and has fallen 61.2% since, to $1,852 in 2025.
Across 82 payments — averaging $165.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$8K
- Axonics, Inc.$2K
- Medtronic$2K
- AbbVie$248
- Avation Medical, Inc.$169
- Coloplast$80
- plus $55 from 1 others
Across 3 payments — averaging $2325.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Axonics, Inc.$7K
What the payments were for
- Consulting fees$5,22639%
- Speaking & faculty fees$4,07330%
- Travel & lodging$1,38110%
- Food & beverage$2,86521%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 29 | $8,475 |
| Axonics, Inc. | 20 | $2,327 |
| Medtronic(2 entities) | 20 | $2,190 |
| AbbVie | 9 | $248 |
| Avation Medical, Inc. | 1 | $169 |
| Coloplast | 1 | $80 |
| Applied Medical Resources Corporation | 2 | $55 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL PELVIC ORGAN PROLAPSE$4,230
- Axonics$1,773
- UPSYLON$1,733
- INTERSTIM$836
- NURO$788
- Bulkamid$614
- GENERAL - THERAPIES$515
- GENERAL FEMALE SUI$360
- SOLYX$357
- Vivally$169
- Solyx SIS System$131
- Axonics r-SNM System$111
- Advantage System$103
How this compares
$13,545 in reported general payments places this provider in the 80th percentile of 62 urogynecology and reconstructive pelvic surgery providers in Illinois.
See all urogynecology and reconstructive pelvic surgery providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 74 | $44,721 |
| MyrbetriqMirabegron | 63 | $35,087 |
| Estradiol | 199 | $11,775 |
| Methenamine Hippurate | 21 | $999 |
| YuvafemEstradiol | 13 | $936 |
| Clobetasol Propionate | 12 | $887 |
| Tolterodine Tartrate ErTolterodine Tartrate | 13 | $332 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 30 | $245 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Chicago
- Abraham ShashouaChicago$339K
- Akira GillinghamChicago$58K
- Kimberly KentonChicago$43K
- Traci BeckChicago$32K
- Margaret MuellerChicago$26K
- Trieu DoChicago$11K
- Sean GeorgeChicago$9K
- Thythy PhamChicago$8K
- Ankita GuptaChicago$7K
- Sarah AdelsteinChicago$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.